Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Roche Holding AG
  6. News
  7. Summary
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

ROCHE HOLDINGS AG : Deutsche Bank reiterates its Buy rating

01/11/2022 | 08:23am EDT
share with twitter
share with LinkedIn
share with facebook

In a research note, Deutsche Bank analyst Emmanuel Papadakis has maintained his recommendation on the stock with a Buy rating. The target price remains unchanged at CHF 425.


© MarketScreener with dpa-AFX Analyser 2022
Stocks mentioned in the article
ChangeLast1st jan.
ON SEMICONDUCTOR CORPORATION -1.01% 55.89 Delayed Quote.-17.71%
ROCHE HOLDING AG 0.05% 324.65 Delayed Quote.-14.40%
All news about ROCHE HOLDING AG
01:01aData at the 2022 ASCO Annual Meeting Highlight Genentech's Continued Commitment to Inno..
BU
01:00aData at the 2022 ASCO Annual Meeting highlight Roche's continued commitment to innovati..
AQ
05/23Roche Secures Exclusive Licensing Deal For KaliVir's Novel Oncolytic Vaccinia Viruses
MT
05/20Biocon Biologics and Viatris Launch Abevmy (bBevacizumab), Their Third Oncology Biosimi..
AQ
05/20Cancer coalition aims to boost access to medicines in poorer countries
RE
05/19ROCHE HOLDINGS AG : Credit Suisse reiterates its Neutral rating
MD
05/18Judgement On The First Drug Patent Linkage Lawsuit In China Is Issued
AQ
05/17AlphaValue/Baader Europe Lifts Price Target on Roche, Maintains Add Recommendation
MT
05/16TRANSCRIPT : Roche Holding AG - Special Call
CI
05/13PUMP / DUMP #31 : The week's gainers and losers
More news
Analyst Recommendations on ROCHE HOLDING AG
More recommendations
Financials
Sales 2022 64 000 M 66 267 M 66 267 M
Net income 2022 14 938 M 15 467 M 15 467 M
Net Debt 2022 10 926 M 11 313 M 11 313 M
P/E ratio 2022 17,2x
Yield 2022 2,99%
Capitalization 264 B 273 B 273 B
EV / Sales 2022 4,29x
EV / Sales 2023 4,12x
Nbr of Employees 100 920
Free-Float 82,4%
Chart ROCHE HOLDING AG
Duration : Period :
Roche Holding AG Technical Analysis Chart | ROG | CH0012032048 | MarketScreener
Technical analysis trends ROCHE HOLDING AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 324,50 CHF
Average target price 396,90 CHF
Spread / Average Target 22,3%
EPS Revisions
Managers and Directors
Severin Schwan Chief Executive Officer & Executive Director
Alan Hippe Chief Financial & Information Officer
Christoph Franz Chairman
Levi A. Garraway Chief Medical Officer
Pascale Schmidt Chief Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
ROCHE HOLDING AG-14.40%273 052
JOHNSON & JOHNSON4.89%472 179
PFIZER, INC.-10.45%296 704
ELI LILLY AND COMPANY9.55%272 388
ABBVIE INC.9.33%261 585
NOVO NORDISK A/S2.29%245 087